PharmaEngine, Inc. (TPEX:4162)

PharmaEngine Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,741	12,974	15,158	17,961	10,207	8,430
Market Cap Growth	-20.00%	-14.41%	-15.60%	75.96%	21.08%	-15.52%
Enterprise Value	4,344	9,241	11,619	14,348	6,496	5,058
Last Close Price	67.80	83.35	95.67	110.57	62.24	47.53
PE Ratio	5.99	7.41	55.19	56.34	23.96	13.95
Forward PE	28.37	10.91	42.71	150.60	109.54	109.54
PS Ratio	3.93	5.14	19.75	27.45	15.59	7.98
PB Ratio	2.09	2.40	3.92	4.64	2.59	2.10
P/TBV Ratio	2.09	2.40	3.93	4.64	2.59	2.10
P/FCF Ratio	5.59	28.46	59.08	90.45	10.98	130.16
P/OCF Ratio	5.58	28.41	58.99	88.91	10.98	130.16
EV/Sales Ratio	1.75	3.66	15.14	21.93	9.92	4.79
EV/EBITDA Ratio	2.13	4.50	41.71	50.62	17.88	6.23
EV/EBIT Ratio	2.14	4.50	41.92	50.75	17.91	6.25
EV/FCF Ratio	2.49	20.27	45.29	72.26	6.99	78.09
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.00	0.01
Debt / EBITDA Ratio	0.00	0.00	0.05	0.08	0.02	0.03
Debt / FCF Ratio	0.00	0.02	0.06	0.11	0.01	0.34
Asset Turnover	0.50	0.52	0.19	0.16	0.16	0.27
Inventory Turnover	1.68	2.16	1.94	2.50	2.46	1.52
Quick Ratio	5.34	13.07	46.50	49.34	45.57	22.41
Current Ratio	5.38	13.15	46.78	49.86	45.71	22.61
Return on Equity (ROE)	38.15%	37.81%	7.10%	8.16%	10.72%	16.13%
Return on Assets (ROA)	25.53%	26.18%	4.37%	4.42%	5.51%	12.89%
Return on Capital (ROIC)	29.62%	27.64%	4.46%	4.51%	5.68%	13.41%
Return on Capital Employed (ROCE)	43.50%	38.00%	7.20%	7.30%	9.20%	20.10%
Earnings Yield	16.74%	13.50%	1.81%	1.77%	4.17%	7.17%
FCF Yield	17.90%	3.51%	1.69%	1.11%	9.11%	0.77%
Dividend Yield	8.85%	7.20%	1.57%	1.81%	4.34%	5.26%
Payout Ratio	13.21%	12.30%	104.57%	121.62%	85.44%	12.05%
Buyback Yield / Dilution	-0.16%	-0.13%	-0.03%	0.72%	0.80%	-0.11%
Total Shareholder Return	8.69%	7.07%	1.54%	2.53%	5.13%	5.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.